{"id":"https://openalex.org/W7140080652","doi":"https://doi.org/10.1158/1538-7445.brain26-a009","title":"Abstract A009: Engineering a novel suite of somatic transgenic murine Egfr-mutant glioblastoma models that recapitulate molecular, immunologic, and functional features of human glioblastoma","display_name":"Abstract A009: Engineering a novel suite of somatic transgenic murine Egfr-mutant glioblastoma models that recapitulate molecular, immunologic, and functional features of human glioblastoma","publication_year":2026,"publication_date":"2026-03-23","ids":{"openalex":"https://openalex.org/W7140080652","doi":"https://doi.org/10.1158/1538-7445.brain26-a009"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.brain26-a009","doi":"https://doi.org/10.1158/1538-7445.brain26-a009","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.brain26-a009","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018100920","display_name":"Joshua J. Breunig","orcid":"https://orcid.org/0000-0002-3735-3390","observed_orcids":["https://orcid.org/0000-0002-3735-3390"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua J. Breunig","raw_affiliation_strings":["1Cedars-Sinai Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cedars-Sinai Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048850369","display_name":"Katie B. Grausam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katie Grausam","raw_affiliation_strings":["1Cedars-Sinai Medical Center, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Cedars-Sinai Medical Center, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040668935","display_name":"Marisa S. Pioso","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marisa Pioso","raw_affiliation_strings":["2UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126339145","display_name":"Julio C. Sanchez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julio Sanchez","raw_affiliation_strings":["2UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033270528","display_name":"David Rincon Fernandez Pacheco","orcid":"https://orcid.org/0000-0002-6998-4920","observed_orcids":["https://orcid.org/0000-0002-6998-4920","https://orcid.org/0000-0001-6217-3757"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Rincon Fernandez Pacheco","raw_affiliation_strings":["3Cedars-Sinai, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cedars-Sinai, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010142965","display_name":"Emily A. Hatanaka","orcid":"https://orcid.org/0000-0001-7615-5728","observed_orcids":["https://orcid.org/0000-0001-7615-5728"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Hatanaka","raw_affiliation_strings":["3Cedars-Sinai, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cedars-Sinai, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026578031","display_name":"Paul W. Linesch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Linesch","raw_affiliation_strings":["3Cedars-Sinai, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cedars-Sinai, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004206249","display_name":"David A. Nathanson","orcid":"https://orcid.org/0000-0002-4919-9159","observed_orcids":["https://orcid.org/0000-0002-4919-9159"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David A. Nathanson","raw_affiliation_strings":["2UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rob M. Prins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rob M. Prins","raw_affiliation_strings":["2UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063600668","display_name":"Stephen Lawrence Shiao","orcid":"https://orcid.org/0000-0001-7586-2885","observed_orcids":["https://orcid.org/0000-0001-7586-2885"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Shiao","raw_affiliation_strings":["3Cedars-Sinai, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Cedars-Sinai, Los Angeles, CA","institution_ids":["https://openalex.org/I1282927834"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"6_Supplement","first_page":"A009","last_page":"A009"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.996999979019165},{"id":"https://openalex.org/keywords/egfrviii","display_name":"EGFRvIII","score":0.8119999766349792},{"id":"https://openalex.org/keywords/transgenic-mouse-model","display_name":"transgenic mouse model","score":0.7059999704360962},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.8410000205039978},{"id":"https://openalex.org/keywords/pten-loss","display_name":"PTEN loss","score":0.8019999861717224},{"id":"https://openalex.org/keywords/cdkn2a-loss","display_name":"CDKN2A loss","score":0.9950000047683716},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-resistance","display_name":"immune checkpoint inhibitor resistance","score":0.7450000047683716},{"id":"https://openalex.org/keywords/t-cell-exhaustion","display_name":"T cell exhaustion","score":0.9430000185966492},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.8349999785423279},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.878000020980835},{"id":"https://openalex.org/keywords/mhc-class-i","display_name":"MHC class I","score":0.7200000286102295},{"id":"https://openalex.org/keywords/microglia","display_name":"microglia","score":0.6909999847412109},{"id":"https://openalex.org/keywords/autochthonous-tumor-model","display_name":"autochthonous tumor model","score":0.7749999761581421},{"id":"https://openalex.org/keywords/crispr-cas9","display_name":"CRISPR/Cas9","score":0.8899999856948853}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.694100022315979},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6507999897003174},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.638700008392334},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.5415999889373779},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.45339998602867126},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4438000023365021},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4399999976158142},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.42170000076293945},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3919999897480011},{"id":"https://openalex.org/C2779830541","wikidata":"https://www.wikidata.org/wiki/Q1622829","display_name":"Microglia","level":3,"score":0.37790000438690186},{"id":"https://openalex.org/C102230213","wikidata":"https://www.wikidata.org/wiki/Q430117","display_name":"Transgene","level":3,"score":0.3709000051021576},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3646000027656555},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3521000146865845},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.34439998865127563},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.3431999981403351},{"id":"https://openalex.org/C141035611","wikidata":"https://www.wikidata.org/wiki/Q5532934","display_name":"Genetically modified mouse","level":4,"score":0.3402000069618225},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.32190001010894775},{"id":"https://openalex.org/C83464605","wikidata":"https://www.wikidata.org/wiki/Q575296","display_name":"Antigen presentation","level":4,"score":0.3203999996185303},{"id":"https://openalex.org/C2779130545","wikidata":"https://www.wikidata.org/wiki/Q233309","display_name":"Brain tumor","level":2,"score":0.3138999938964844},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.31139999628067017},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3091999888420105},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.30809998512268066},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3073999881744385},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.305400013923645},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.29670000076293945},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.28859999775886536},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.2797999978065491},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.2791999876499176},{"id":"https://openalex.org/C128473837","wikidata":"https://www.wikidata.org/wiki/Q7863603","display_name":"U87","level":3,"score":0.2718000113964081},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.26510000228881836},{"id":"https://openalex.org/C2776662205","wikidata":"https://www.wikidata.org/wiki/Q2459684","display_name":"Tumor antigen","level":4,"score":0.26089999079704285},{"id":"https://openalex.org/C2777761686","wikidata":"https://www.wikidata.org/wiki/Q715347","display_name":"Lymphocyte","level":2,"score":0.25540000200271606}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.brain26-a009","doi":"https://doi.org/10.1158/1538-7445.brain26-a009","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.brain26-a009","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":[],"abstract_inverted_index":{"Abstract":[0],"Glioblastoma":[1],"(GBM)":[2],"is":[3],"the":[4,43,185,223,227,298],"most":[5,186],"common":[6],"and":[7,22,79,99,113,121,141,177,193,233,239,288],"deadly":[8],"primary":[9],"brain":[10],"tumor":[11,25,84],"in":[12,35,104,125,208,237,302],"adults,":[13],"characterized":[14,108],"by":[15],"diffuse":[16],"infiltrative":[17,136],"lesions,":[18],"distinct":[19],"oncogenic":[20],"alterations,":[21],"a":[23,52,109,142,205,274],"suppressive":[24],"immune":[26,166],"microenvironment":[27],"(TIME).":[28],"These":[29],"traits,":[30],"however,":[31],"are":[32],"not":[33],"recapitulated":[34],"current":[36],"syngeneic":[37],"murine":[38,57,91,200,280],"glioma":[39,129],"models":[40,59,85,283],"thereby":[41],"limiting":[42],"pre-clinical":[44],"development":[45],"of":[46,90,150,213,226,277,291,297],"novel":[47,241,275],"therapies.":[48],"Here":[49],"we":[50,81],"describe":[51],"molecular":[53],"toolkit":[54],"for":[55,244],"developing":[56,238],"GBM":[58],"with":[60,67,73,86,138,152,210],"patient-specific":[61],"mutations":[62,101],"that":[63,284],"share":[64],"striking":[65],"resemblance":[66],"human":[68,292],"disease.":[69],"Leveraging":[70],"mosaic":[71],"analysis":[72],"dual-recombinase":[74],"mediated":[75],"cassette":[76],"exchange":[77],"(MADR)":[78],"CRISPR-Cas9,":[80],"generated":[82],"autochthonous":[83],"single-copy":[87],"somatic":[88,278],"transgenesis":[89],"epidermal":[92],"growth":[93],"factor":[94],"receptor":[95],"variant":[96],"III":[97],"(mEGFRvIII)":[98],"loss-of-function":[100],"commonly":[102],"observed":[103],"GBM.":[105,245],"We":[106],"further":[107],"model":[110,229],"lacking":[111],"PTEN":[112],"CDKN2A":[114],"(mEGFRvIII-PC)":[115],"via":[116],"histopathologic":[117],"analyses,":[118],"functional":[119,289],"assays,":[120],"single-cell":[122],"RNA":[123],"sequencing":[124],"comparison":[126],"to":[127,165,171,188,216,230],"existing":[128],"models.":[130],"mEGFRvIII-PC":[131,182,228],"tumors":[132,161,232],"developed":[133],"as":[134],"diffuse,":[135],"lesions":[137],"ill-defined":[139],"margins":[140],"necrotic":[143],"core.":[144],"The":[145],"TIME":[146],"was":[147],"primarily":[148],"comprised":[149],"microglia":[151],"minimal":[153],"lymphocyte":[154],"infiltration,":[155],"recapitulating":[156],"patient":[157,231],"tumors.":[158],"Furthermore,":[159],"these":[160,220],"displayed":[162],"intrinsic":[163],"resistance":[164],"checkpoint":[167],"blockade,":[168],"potentially":[169],"due":[170],"poor":[172],"myeloid":[173],"cell":[174,179,197],"antigen":[175],"presentation":[176],"T":[178,190,196],"priming.":[180],"Additionally,":[181],"cells":[183],"were":[184],"resistant":[187],"antigen-specific":[189],"cell-induced":[191],"cytotoxicity":[192],"simultaneously":[194],"promoted":[195],"exhaustion,":[198],"while":[199],"interferon-\u03b3":[201],"(mIFN-\u03b3)":[202],"stimulation":[203],"induced":[204],"greater":[206],"response":[207],"vitro":[209],"enhanced":[211],"upregulation":[212],"PD-L1":[214],"relative":[215],"MHC-I.":[217],"In":[218],"sum,":[219],"findings":[221],"demonstrate":[222],"superior":[224],"fidelity":[225],"support":[234],"its":[235],"use":[236],"refining":[240],"therapeutic":[242],"paradigms":[243],"Citation":[246],"Format:":[247],"Joshua":[248],"J.":[249],"Breunig,":[250],"Katie":[251],"Grausam,":[252],"Marisa":[253],"Pioso,":[254],"Julio":[255],"Sanchez,":[256],"David":[257,265],"Rincon":[258],"Fernandez":[259],"Pacheco,":[260],"Emily":[261],"Hatanaka,":[262],"Paul":[263],"Linesch,":[264],"A.":[266],"Nathanson,":[267],"Rob":[268],"M.":[269],"Prins,":[270],"Stephen":[271],"Shiao.":[272],"Engineering":[273],"suite":[276],"transgenic":[279],"Egfr-mutant":[281],"glioblastoma":[282,293],"recapitulate":[285],"molecular,":[286],"immunologic,":[287],"features":[290],"[abstract].":[294],"In:":[295],"Proceedings":[296],"AACR":[299],"Special":[300],"Conference":[301],"Cancer":[303,315],"Research:":[304],"Brain":[305],"Cancer;":[306],"2026":[307],"Mar":[308],"23-25;":[309],"Philadelphia,":[310],"PA.":[311],"Philadelphia":[312],"(PA):":[313],"AACR;":[314],"Res":[316],"2026;86(6_Suppl):Abstract":[317],"nr":[318],"A009.":[319]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2026-03-24T00:00:00"}